Title: Treating Age-Related Macular Degeneration – Interaction of VEGF-Antagonists with their Target
Volume: 9
Issue: 9
Author(s): A. Klettner and J. Roider
Affiliation:
Keywords:
VEGF, ranibizumab, lucentis, AMD, pegaptanib, VEGF-trap
Abstract: The neutralization of VEGF is the current treatment of choice for age-related macular degeneration. Current approaches include anti-VEGF-antibodies and – Fab Fragments, aptamers, soluble receptors (Traps) and siRNA. The molecular properties of VEGF and its antagonists are reviewed and the pathways of action of these substances are discussed.